VITALHUB CORP (VHI.CA) Stock Fundamental Analysis
Canada - Toronto Stock Exchange - TSX:VHI - CA92847V5018 - Common Stock
8.45 CAD
-0.2 (-2.31%)
Taking everything into account, VHI scores 6 out of 10 in our fundamental rating. VHI was compared to 9 industry peers in the Health Care Technology industry. VHI has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. VHI is growing strongly while it is still valued neutral. This is a good combination! These ratings would make VHI suitable for growth and quality investing!
1. Profitability
1.1 Basic Checks
- In the past year VHI was profitable.
- VHI had a positive operating cash flow in the past year.
- In multiple years VHI reported negative net income over the last 5 years.
- VHI had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
- The Return On Assets of VHI (0.76%) is better than 88.89% of its industry peers.
- Looking at the Return On Equity, with a value of 1.08%, VHI belongs to the top of the industry, outperforming 88.89% of the companies in the same industry.
- VHI has a better Return On Invested Capital (2.86%) than 100.00% of its industry peers.
- Measured over the past 3 years, the Average Return On Invested Capital for VHI is in line with the industry average of 2.16%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.76% | ||
| ROE | 1.08% | ||
| ROIC | 2.86% |
ROA(3y)2.14%
ROA(5y)0.07%
ROE(3y)3.08%
ROE(5y)0.28%
ROIC(3y)3.96%
ROIC(5y)N/A
1.3 Margins
- Looking at the Profit Margin, with a value of 2.88%, VHI belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
- With an excellent Operating Margin value of 12.47%, VHI belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
- In the last couple of years the Operating Margin of VHI has grown nicely.
- The Gross Margin of VHI (80.92%) is better than 88.89% of its industry peers.
- In the last couple of years the Gross Margin of VHI has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 12.47% | ||
| PM (TTM) | 2.88% | ||
| GM | 80.92% |
OM growth 3Y125.53%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.9%
GM growth 5Y2.08%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), VHI is destroying value.
- The number of shares outstanding for VHI has been increased compared to 1 year ago.
- The number of shares outstanding for VHI has been increased compared to 5 years ago.
- Compared to 1 year ago, VHI has an improved debt to assets ratio.
2.2 Solvency
- VHI has an Altman-Z score of 3.67. This indicates that VHI is financially healthy and has little risk of bankruptcy at the moment.
- VHI has a Altman-Z score of 3.67. This is comparable to the rest of the industry: VHI outperforms 55.56% of its industry peers.
- The Debt to FCF ratio of VHI is 0.13, which is an excellent value as it means it would take VHI, only 0.13 years of fcf income to pay off all of its debts.
- Looking at the Debt to FCF ratio, with a value of 0.13, VHI belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
- A Debt/Equity ratio of 0.00 indicates that VHI is not too dependend on debt financing.
- VHI has a Debt to Equity ratio of 0.00. This is amongst the best in the industry. VHI outperforms 88.89% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.13 | ||
| Altman-Z | 3.67 |
ROIC/WACC0.33
WACC8.66%
2.3 Liquidity
- VHI has a Current Ratio of 1.94. This is a normal value and indicates that VHI is financially healthy and should not expect problems in meeting its short term obligations.
- VHI has a better Current ratio (1.94) than 77.78% of its industry peers.
- A Quick Ratio of 1.94 indicates that VHI should not have too much problems paying its short term obligations.
- The Quick ratio of VHI (1.94) is better than 77.78% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.94 | ||
| Quick Ratio | 1.94 |
3. Growth
3.1 Past
- VHI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -14.29%.
- VHI shows a strong growth in Revenue. In the last year, the Revenue has grown by 59.34%.
- Measured over the past years, VHI shows a very strong growth in Revenue. The Revenue has been growing by 46.32% on average per year.
EPS 1Y (TTM)-14.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-133.33%
Revenue 1Y (TTM)59.34%
Revenue growth 3Y40.63%
Revenue growth 5Y46.32%
Sales Q2Q%94.1%
3.2 Future
- The Earnings Per Share is expected to grow by 70.74% on average over the next years. This is a very strong growth
- Based on estimates for the next years, VHI will show a very strong growth in Revenue. The Revenue will grow by 27.33% on average per year.
EPS Next Y-6.21%
EPS Next 2Y86.09%
EPS Next 3Y70.74%
EPS Next 5YN/A
Revenue Next Year60.05%
Revenue Next 2Y38.57%
Revenue Next 3Y27.33%
Revenue Next 5YN/A
3.3 Evolution
- The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 140.83, which means the current valuation is very expensive for VHI.
- Compared to the rest of the industry, the Price/Earnings ratio of VHI indicates a rather cheap valuation: VHI is cheaper than 100.00% of the companies listed in the same industry.
- VHI's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.47.
- With a Price/Forward Earnings ratio of 34.86, VHI can be considered very expensive at the moment.
- Based on the Price/Forward Earnings ratio, VHI is valued cheaply inside the industry as 88.89% of the companies are valued more expensively.
- When comparing the Price/Forward Earnings ratio of VHI to the average of the S&P500 Index (24.26), we can say VHI is valued slightly more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 140.83 | ||
| Fwd PE | 34.86 |
4.2 Price Multiples
- 100.00% of the companies in the same industry are more expensive than VHI, based on the Enterprise Value to EBITDA ratio.
- 100.00% of the companies in the same industry are more expensive than VHI, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 43.78 | ||
| EV/EBITDA | 19.42 |
4.3 Compensation for Growth
- The decent profitability rating of VHI may justify a higher PE ratio.
- A more expensive valuation may be justified as VHI's earnings are expected to grow with 70.74% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y86.09%
EPS Next 3Y70.74%
5. Dividend
5.1 Amount
- No dividends for VHI!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
TSX:VHI (1/16/2026, 7:00:00 PM)
8.45
-0.2 (-2.31%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)11-06 2025-11-06/amc
Earnings (Next)03-16 2026-03-16
Inst Owners40.16%
Inst Owner ChangeN/A
Ins Owners11.45%
Ins Owner ChangeN/A
Market Cap533.36M
Revenue(TTM)98.17M
Net Income(TTM)2.83M
Analysts81.33
Price Target15.51 (83.55%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-78.71%
Min EPS beat(2)-129.12%
Max EPS beat(2)-28.31%
EPS beat(4)0
Avg EPS beat(4)-61.43%
Min EPS beat(4)-129.12%
Max EPS beat(4)-28.31%
EPS beat(8)0
Avg EPS beat(8)-58.34%
EPS beat(12)1
Avg EPS beat(12)-46.79%
EPS beat(16)2
Avg EPS beat(16)-54.73%
Revenue beat(2)2
Avg Revenue beat(2)9.95%
Min Revenue beat(2)7.24%
Max Revenue beat(2)12.66%
Revenue beat(4)4
Avg Revenue beat(4)6.3%
Min Revenue beat(4)0.61%
Max Revenue beat(4)12.66%
Revenue beat(8)6
Avg Revenue beat(8)4.15%
Revenue beat(12)10
Avg Revenue beat(12)4.05%
Revenue beat(16)12
Avg Revenue beat(16)4.16%
PT rev (1m)0%
PT rev (3m)-1.75%
EPS NQ rev (1m)-25%
EPS NQ rev (3m)-41.67%
EPS NY rev (1m)-4.1%
EPS NY rev (3m)-44.09%
Revenue NQ rev (1m)0.57%
Revenue NQ rev (3m)4.7%
Revenue NY rev (1m)0.42%
Revenue NY rev (3m)4.24%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 140.83 | ||
| Fwd PE | 34.86 | ||
| P/S | 5.43 | ||
| P/FCF | 43.78 | ||
| P/OCF | 41.29 | ||
| P/B | 2.04 | ||
| P/tB | 10.83 | ||
| EV/EBITDA | 19.42 |
EPS(TTM)0.06
EY0.71%
EPS(NY)0.24
Fwd EY2.87%
FCF(TTM)0.19
FCFY2.28%
OCF(TTM)0.2
OCFY2.42%
SpS1.56
BVpS4.15
TBVpS0.78
PEG (NY)N/A
PEG (5Y)N/A
Graham Number2.37
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.76% | ||
| ROE | 1.08% | ||
| ROCE | 4.19% | ||
| ROIC | 2.86% | ||
| ROICexc | 4.95% | ||
| ROICexgc | N/A | ||
| OM | 12.47% | ||
| PM (TTM) | 2.88% | ||
| GM | 80.92% | ||
| FCFM | 12.41% |
ROA(3y)2.14%
ROA(5y)0.07%
ROE(3y)3.08%
ROE(5y)0.28%
ROIC(3y)3.96%
ROIC(5y)N/A
ROICexc(3y)5.88%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)5.82%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y132.1%
ROICexc growth 5YN/A
OM growth 3Y125.53%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.9%
GM growth 5Y2.08%
F-Score3
Asset Turnover0.27
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.13 | ||
| Debt/EBITDA | 0.05 | ||
| Cap/Depr | 7.67% | ||
| Cap/Sales | 0.75% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 59.17% | ||
| Profit Quality | 430.43% | ||
| Current Ratio | 1.94 | ||
| Quick Ratio | 1.94 | ||
| Altman-Z | 3.67 |
F-Score3
WACC8.66%
ROIC/WACC0.33
Cap/Depr(3y)9.42%
Cap/Depr(5y)8.61%
Cap/Sales(3y)0.86%
Cap/Sales(5y)0.89%
Profit Quality(3y)466.06%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-14.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-133.33%
EPS Next Y-6.21%
EPS Next 2Y86.09%
EPS Next 3Y70.74%
EPS Next 5YN/A
Revenue 1Y (TTM)59.34%
Revenue growth 3Y40.63%
Revenue growth 5Y46.32%
Sales Q2Q%94.1%
Revenue Next Year60.05%
Revenue Next 2Y38.57%
Revenue Next 3Y27.33%
Revenue Next 5YN/A
EBIT growth 1Y46.83%
EBIT growth 3Y217.15%
EBIT growth 5YN/A
EBIT Next Year76.68%
EBIT Next 3Y40.05%
EBIT Next 5YN/A
FCF growth 1Y-12.77%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-10.32%
OCF growth 3YN/A
OCF growth 5YN/A
VITALHUB CORP / VHI.CA FAQ
What is the fundamental rating for VHI stock?
ChartMill assigns a fundamental rating of 6 / 10 to VHI.CA.
What is the valuation status of VITALHUB CORP (VHI.CA) stock?
ChartMill assigns a valuation rating of 5 / 10 to VITALHUB CORP (VHI.CA). This can be considered as Fairly Valued.
Can you provide the profitability details for VITALHUB CORP?
VITALHUB CORP (VHI.CA) has a profitability rating of 7 / 10.
Can you provide the financial health for VHI stock?
The financial health rating of VITALHUB CORP (VHI.CA) is 7 / 10.